期刊文献+

不同转染方式对GFP表达质粒在小鼠肝脏的表达影响 被引量:3

Comparison of different non-viral transfection methods for GFP plasmid expression in the liver of mice
原文传递
导出
摘要 目的研究经流体力学注射、门静脉和腹腔常规注射3种不同途径注射GFP表达质粒后,目的基因在小鼠肝脏的表达情况及其转基因效率。方法将裸质粒或脂质体包裹的质粒DNA分别应用流体力学注射、门静脉及腹腔常规注射法注入同种异体小鼠体内,48h后分别取血和肝组织,通过荧光显微镜观察3种转染途径对质粒DNA在小鼠肝脏的表达影响。结果流体力学注射组及门静脉常规注射组均可见大量绿色荧光蛋白表达,两组的荧光表达量差异无统计学意义(P>0.05),腹腔注射组小鼠的肝脏仅见少量的绿色荧光表达,但3组内脂质体/质粒DNA复合物组绿色荧光表达量均明显高于裸质粒组(P<0.05)。结论应用流体力学注射及门静脉常规注射脂质体/质粒DNA复合物途径,目的基因均在小鼠肝脏高效表达,两种途径无明显差异,流体力学注射可广泛用于肝靶向性的活体基因转染。 Objective To compare the transfection efficiency and expression intensity of a green fluorescent protein (GFP) reporter gene in the liver of mice by using three non-viral transfection methods,i.e.,hydrodynamic injection,portal vein injection and peritoneal injection. Methods The naked GFP plasmids or liposome encapsulated plasmids were injected via the tail vein or portal vein or abdominal cavity of different mice with homogeneity. The blood and the liver were harvested 48 h after injection,and the contents of alanine aminotransferase (ALT) and total bilirubin (TB) were detected in serum. Also,expression intensity of GFP was evaluated by fluorescence microscopy. Results Of the three transfection methods employed,hydrodynamic gene delivery and portal vein injection conferred a stronger expression of GFP with a similar transfection efficiency (P〉0.05). However,after encapsulation by liposomes,the expression level of GFP was significantly higher than that of naked plasmid DNA. Conclusion High level gene expression in mouse liver can be achieved by hydrodynamic injection or portal vein injection of liposome encapsulated plasmid DNA,and hepatic delivery of the foreign gene can be accomplished by hydrodynamics-based injection.
出处 《山东大学学报(医学版)》 CAS 北大核心 2010年第1期17-20,共4页 Journal of Shandong University:Health Sciences
关键词 GFP表达质粒 流体力学注射 门静脉 基因疗法 GFP plasmid Hydrodynamic injection Portal vein Gene therapy
  • 相关文献

参考文献10

  • 1Liu F, Song Y K, Liu D. Hydrodynamics-based transfecfion in animals by systemic administration of plasmid DNA[J]. Gene Ther, 1999, 6:1258-1266.
  • 2刘亮明,罗杰,张吉翔,郭宏兴,邓欢.裸质粒流体力学注射法-基因治疗研究的利器[J].世界华人消化杂志,2006,14(28):2780-2784. 被引量:2
  • 3Andrianaivo F, Lecocq M, Wattiaux-De Coninek S, et al. Hydrodynamics -based transfection of the liver: entrance into hepatocytes of DNA that causes expression takes place very early after injection[J]. Gene Med, 2004, 6:877-883.
  • 4Kobayashi N, Nishikawa M, Takakura Y. The hydrodynamics- based procedure for controlling the pharmacokinefics of gene medicines at whole body, organ and cellular levels [ J]. Adv Drug Deliv Rev, 2005, 57:713-731.
  • 5Kobayashi N, Nishikawa M, Hirata K, et al. Hydrodynamicsbased procedure involves transient hyperpermeability in the hepatic cellular membrane: implication of a nonspecific process in efficient intracellular gene delivery[J]. Gene Med, 2004, 6: 584-592.
  • 6Goodwin P C. GFP biofluorescence: imagining gene expression and protein dynamics in living cells. Design considerations for a fluorescence imagining laboratory[ J]. Meth Cell Biol, 1999, 58: 343-367.
  • 7Li X, Zhang G, Ngo N, et al. Deletions of the acquorea Victoria green fluorescent protein define the minimal domain required for fluorescence [ J ]. Biol Chem, 1997, 272 (45) : 28545- 28549.
  • 8Felnger P L, Gadek T R, Holn M. et al. Lipofection: a high efficient lipid-mediated DNA-transfecfion procedure[J]. Pmc Natl Acad Sci USA, 1987, 84:7413-7417.
  • 9Obedle V, Bakow U. Lipoplex formation under equilibrium condition reveals a three-step mechanicsm [ J]. Biophy J, 2000, 79(9) : 1447-1454.
  • 10邓益斌,秦爱萍,朱晓莹,王燕菲.阳离子脂质体作为基因治疗药物载体在小鼠体内的毒性研究[J].现代生物医学进展,2008,8(12):2238-2241. 被引量:3

二级参考文献40

  • 1李劲松,叶展,赵涵芳,陈诗书.阳离子脂质体介导的基因转染真核细胞的研究[J].上海第二医科大学学报,2005,25(10):1025-1029. 被引量:8
  • 2孙瑞琳,金发光,吴道澄,吴红,南鹏娟,张颖,刘斌.多聚胺阳离子脂质体转染体系的构建[J].中国现代医学杂志,2006,16(18):2751-2754. 被引量:2
  • 3Yang PL,Althage A,Chung J,Chisari FV.Hydrodynamic injection of viral DNA:a mouse model of acute hepatitis B virus infection.Proc Natl Acad Sci USA 2002; 99:13825-13830
  • 4Yokoi H,Mukoyama M,Nagae T,Mori K,Suganami T,Sawai K,Yoshioka T,Koshikawa M,Nishida T,Takigawa M,Sugawara A,Nakao K.Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis.J Am Soc Nephrol 2004; 15:1430-1440
  • 5Chang J,Sigal LJ,Lerro A,Taylor J.Replication of the human hepatitis delta virus genome Is initiated in mouse hepatocytes following intravenous injection of naked DNA or RNA sequences.J Virol 2001;75:3469-3473
  • 6Kobayashi N,Kuramoto T,Yamaoka K,Hashida M,Takakura Y.Hepatic uptake and gene expression mechanisms following intravenous administration of plasmid DNA by conventional and hydrodynamics-based procedures.J Pharmacol Exp Ther 2001;297:853-860
  • 7Hofman CR,Dileo JP,Li Z,Li S,Huang L.Efficient in vivo gene transfer by PCR amplified fragment with reduced inflammatory activity.Gene Ther 2001; 8:71-74
  • 8Kobayashi N,Matsui Y,Kawase A,Hirata K,Miyagishi M,Taira K,Nishikawa M,Takakura Y.Vectorbased in vivo RNA interference:dose-and timedependent suppression of transgene expression.J Pharmacol Exp Ther 2004; 308:688-693
  • 9Matsui Y,Kobayashi N,Nishikawa M,Takakura Y.Sequence-specific suppression of mdr1a/1b expression in mice via RNA interference.Pharm Res 2005;22:2091-2098
  • 10Takahashi Y,Nishikawa M,Kobayashi N,Takakura Y.Gene silencing in primary and metastatic tumors by small interfering RNA delivery in mice:quantitative analysis using melanoma cells expressing firefly and sea pansy luciferases.J Control Release 2005; 105:332-343

共引文献3

同被引文献23

  • 1赵世峰.急性肝衰竭动物模型的建立[J].世界急危重病医学杂志,2006,3(2):1224-1228. 被引量:2
  • 2胡敏,陈光宇.细胞因子作为DNA疫苗佐剂的研究进展[J].生物技术通讯,2007,18(3):480-482. 被引量:6
  • 3Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell,2008,132:27 -42.
  • 4Uchiyama Y, Shibata M, Koike M, et al. Autophagy-physiology and pathophysiology. Histochem Cell Biol,2008,129:407-420.
  • 5Mizushima N, Yoshimori T, Levine B. Methods in mammalian au- tophagy research. Cell,2010,140:313-326.
  • 6Li SL, Tang ZQ, Yu H, et al. Administration of naked plasmid en- coding hepatic stimulator substance by hydrodynamic tail vein in- jection protects mice from hepatic failure by suppressing the mitochondrial permeability transition. J Pharmacol Exp Ther,2011,338:750-757.
  • 7Edelstein ML,,Abedi MR,Wixon J.Gene therapy clinical trials world-wide to 2007—an update. The Journal of Gene Medicine . 2007
  • 8Blaese RM,Culver KW,Miller AD,et al.T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science . 1995
  • 9Trollet C,Bloquel C,Scherman D,et al.Electrotransfer into skeletal muscle for protein expression. Current Gene Therapy . 2006
  • 10Cemazar M,Sersa G.Electrotransfer of therapeuticmolecules into tissues. Curr Opin Molecul Ther . 2007

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部